Biomea Fusion Inc Stock - BMEA Share Price Today, News and Discussion

Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in Redwood City, CA.

Sector:

Health Technology

Industry:

Pharmaceuticals Major

Employees:

51

Current Price	$9.55
Prev Close	$9.52
Open	$9.53
Dividend Yield	0.00%
50-Day Moving Average	$7.81
Beta	0.00
Avg. Volume	55,519.60
PE Ratio	N/A

52-Week High	$14.20
52-Week Low	$2.84
Market Capitalization	$280.73M
EPS	-$2.44
Price to Book	1.86
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-3.37

No BMEA news at the moment.

BMEA Biomea Fusion Inc

About

Feed

Fundamentals

News